Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
Eli Lilly reunites with Abbisko in $1.9B, multitarget R&D pact
Lilly has expanded its ties to Abbisko, committing up to $1.9 billion to get the Chinese biotech to apply its capabilities to multiple targets.
Nick Paul Taylor
Jun 24, 2026 7:47am
Takeda ends mRNA research pact with Japanese drug discoverer
Apr 14, 2026 9:57am
Merck hands over $20M in IBD target deal with Quotient
Mar 24, 2026 6:00am
Gilead's $2.2B Ouro buy delivers TCE, new purpose for Galapagos
Mar 24, 2026 3:34am
Astellas ends $1.6B biobucks TCE pact with CytomX after 6 years
Mar 16, 2026 10:12am
Biotech unit Pfizer Ignite flames out
Mar 12, 2026 3:58pm
